Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes

NCT06333132 is registered in ClinicalTrials.gov with Azienda Ospedaliero, Universitaria Pisana as lead sponsor.

NCT NCT06333132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06333132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes
Lead sponsor
Azienda Ospedaliero, Universitaria Pisana
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2024
Completion date
February 1, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2 in obese, obesity